[HTML][HTML] Targeting histone modifications in breast cancer: a precise weapon on the way

W Li, H Wu, S Sui, Q Wang, S Xu… - Frontiers in cell and …, 2021 - frontiersin.org
Histone modifications (HMs) contribute to maintaining genomic stability, transcription, DNA
repair, and modulating chromatin in cancer cells. Furthermore, HMs are dynamic and …

[HTML][HTML] The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67

JY Kim, HS Jeong, T Chung, M Kim, JH Lee, WH Jung… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Background Established measurements of proliferation in breast cancer are Ki67 and mitotic-
activity-index (MAI), with problems in reproducibility and prognostic accuracy …

Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer

G Stålhammar, S Robertson, L Wedlund… - …, 2018 - Wiley Online Library
Aims During pathological examination of breast tumours, proliferative activity is routinely
evaluated by a count of mitoses. Adding immunohistochemical stains of Ki67 provides extra …

Clinical and histopathological predictors of outcome in malignant meningioma

AD Maier, J Bartek, F Eriksson, H Ugleholdt… - Neurosurgical …, 2020 - Springer
We investigated possible clinical and histopathological prognostic factors in a malignant
meningioma cohort with comprehensive long-term population-based follow-up data. Twenty …

[PDF][PDF] What is the biological function of uric acid? An antioxidant for neural protection or a biomarker for cell death

D Liu, Y Yun, D Yang, X Hu, X Dong… - Disease …, 2019 - downloads.hindawi.com
The main aim of the present study was to investigate the biological function of uric acid. The
level of uric acid in different organs in normal male rats was determined with uric acid assay …

Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice

EJ Campbell, MCM Vissers, C Wohlrab… - Free Radical Biology …, 2016 - Elsevier
Despite recent evidence for an anti-tumour role for high-dose ascorbate, potential
mechanisms of action are still unclear. At mM concentrations that are achieved with high …

Improving mitotic cell counting accuracy and efficiency using phosphohistone‐H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast …

A Ibrahim, MS Toss, S Makhlouf, IM Miligy… - …, 2023 - Wiley Online Library
Background Mitotic count in breast cancer is an important prognostic marker. Unfortunately,
substantial inter‐and intraobserver variation exists when pathologists manually count mitotic …

MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ

Q Guo, VZ Li, JN Nichol, F Huang, W Yang… - Cancer research, 2019 - AACR
The mechanisms by which breast cancers progress from relatively indolent ductal carcinoma
in situ (DCIS) to invasive ductal carcinoma (IDC) are not well understood. However, this …

[HTML][HTML] Uric acid, metabolism, neuro-endocrine-immune complex, 258 s.

AI Gozhenko, MM Korda, VS Smagliy, NS Badiuk… - 2023 - repozytorium.umk.pl
Gozhenko AI, Korda MM, Smagliy VS, Badiuk NS, Zukow W, Klishch MI, Korda IV,
Bombushkar IS, Popovych IL. Uric Acid, Metabolism, Neuro-Endocrine-Immine Complex …

Prognostic utility of atypical mitoses in patients with breast cancer: a comparative study with Ki67 and phosphohistone H3

R Ohashi, S Namimatsu, T Sakatani… - Journal of surgical …, 2018 - Wiley Online Library
Background and Objectives Emerging evidence suggests that the presence of atypical
mitoses is associated with poor prognosis in some types of cancer, but its clinical …